ARTICLES
9. Akey, D. L. et al. Structural basis for macrolactonization by the pikromycin
thioesterase. Nature Chem. Biol. 2, 537–542 (2006).
10. Zhou, H., Qiao, K., Gao, Z., Vederas, J. C. & Tang, Y. Insights into radicicol
biosynthesis via heterologous synthesis of intermediates and analogs. J. Biol.
Chem. 285, 41412–41421 (2010).
11. Forouhar, F. et al. Structural and biochemical studies identify tobacco SABP2
as a methyl salicylate esterase and implicate it in plant innate immunity.
Proc. Natl Acad. Sci. 102, 1773–1778 (2005).
12. Grabowski, S. L. Hydrogen Bond — New Insights (Springer, 2006).
13. Kwon, H. C., Kauffman, C. A., Jensen, P. R. & Fenical, W. Marinomycins A–D,
antitumor-antibiotics of a new structure class from a marine actinomycete
of the recently discovered genus ‘Marinispora’. J. Am. Chem. Soc. 128,
1622–1632 (2006).
14. Chambers, H. F. & DeLeo, F. R. Waves of resistance: Staphylococcus aureus
in the antibiotic era. Nature Rev. Microbiol. 7, 629–641 (2009).
15. Murray, B. E. Vancomycin-resistant enterococcal infections. N. Engl. J. Med.
342, 710–721 (2000).
16. Matsumori, N., Yamaji, N., Matsuoka, S., Oishi, T. & Murata, M. Amphotericin
B covalent dimers forming sterol-dependent ion-permeable membrane
channels. J. Am. Chem. Soc. 124, 4180–4181 (2002).
17. Nicolaou, K. C. et al. Total synthesis of marinomycins A–C and of their
monomeric counterparts monomarinomycin A and iso-monomarinomycin A.
J. Am. Chem. Soc. 129, 1760–1768 (2007).
18. Amans, D., Bareille, L., Bellosta, V. & Cossy, J. Synthesis of the monomeric
counterpart of marinomycin A. J. Org. Chem. 74, 7665–7674 (2009).
19. Hoffmann, R. W. Conformation design of open-chain compounds. Angew.
Chem. Int. Ed. 39, 2054–2070 (2000).
24 in 94% yield. Although the protection of the phenols formally acti-
vates both salicylate esters, we envisioned that the syn-1,3-dioxane
would enforce a linear conformation to promote the formation of
the macrodiolide rather than the macrolide19. Deprotection of the
tert-butyldimethylsilyloxy and (trimethylsilyl)ethoxy protecting
groups provided the seco-acid, which was subjected to macrolactoni-
zation using the modified Mukaiyama salt to furnish the 44-mem-
bered C2-symmetrical macrodiolide 25 in 34% yield (two steps)30.
Although there was no evidence of macrolide formation, the low
overall yield is attributed to a combination of complications with
the deprotection of the silyl protecting groups and the conversion of
the methoxymethyl aryl ether of seco-acid to the corresponding
monofluoromethyl phenyl ether. Global deprotection of macrodiolide
25 under carefully optimized reaction conditions furnished
marinomycin A (1) in 61% isolated yield after reverse-phase high-
performance liquid chromatography purification. Interestingly,
rapid hydrolysis of the aryl methoxymethyl ethers in 25 deactivates
the salicylate esters to hydrolysis in this challenging deprotection
sequence, which further illustrates the role of the resonance-assisted
hydrogen bond (RAHB) in this class of molecules. The spectro-
scopic data and optical rotation of synthetic marinomycin A (1)
were identical in all respects to the values reported for the natural
substance (1H/13C NMR, IR, [a]2D3 þ 168 (c 0.09, EtOH)
[lit.13 [a]D þ 180 (c 0.11, EtOH)]) by Fenical and co-workers13.
In summary, we describe a highly convergent asymmetric total
synthesis of (þ)-marinomycin A (1) using a triply convergent
18-step sequence (longest linear sequence) in 3.5% overall
yield. A key feature of the synthesis is the recognition of the role
that salicylate has in modulating the reactivity and conformation
via an intramolecular RAHB or the corresponding phenoxide; this
raises important new questions with regard to the biosynthesis,
conformation and biological activity of macrodiolides that contain
salicyclates. An additional feature of the synthesis is the ability to
utilize a syn-1,3-dioxane to facilitate a conformation-assisted
macrolactonization to preferentially afford the macrodiolide.
These observations have prompted biological studies to gain a
better understanding of the biosynthetic assembly of salicylate-
containing macrolide and macrodiolide natural products. Finally,
we believe that salicylates may have evolved as amide surrogates,
which may prove useful in bioorganic and medicinal chemistry.
20. Smith, A. B. III & Xian, M. Anion relay chemistry: an effective tactic for diversity
oriented synthesis. J. Am. Chem. Soc. 128, 66–67 (2006).
21. Keck, G. E. & Wager, C. A. The first directed reduction of b-alkoxy ketones to
anti-1,3-diol monoethers: Identification of spectator and director alkoxy groups.
Org. Lett. 2, 2307–2309 (2000).
22. Bernet B. & Vasella A. Carbocyclische verbindungen aus Monosacchariden.
I. Umsetzungen in der Glucosereihe. Helv. Chim. Acta. 62, 1990–2016 (1979).
23. Evans, P. A., Grisin, A. & Lawler, M. J. Diastereoselective construction of
syn-1,3-dioxanes via a bismuth-mediated two-component hemiacetal/oxa-
conjugate reaction. J. Am. Chem. Soc. 134, 2856–2859 (2012).
24. Michels, T. D., Rhee, J. U. & Vanderwal, C. D. Synthesis of d-tributylstannyl-
a,b,g,d-unsaturated aldehydes from pyridines. Org. Lett. 10, 4787–4790 (2008).
25. Uchiyama, M. et al. Regiocontrolled intramolecular cyclizations of carboxylic
acids to carbon–carbon triple bonds promoted by acid or base catalyst. Org. Lett.
8, 5517–5520 (2006).
26. Chatterjee, A. K., Choi, T.-L., Sanders, D. P. & Grubbs, R. H. A general model for
selectivity in olefin cross metathesis. J. Am. Chem. Soc. 125, 11360–11370 (2003).
27. Hassan, A. E. A., Nishizono, N., Minakawa, N., Shuto, S. & Matsuda A.
Nucleosides and nucleotides. 151. Conversion of (Z)-2′-(cyanomethylene)-
2′-deoxyuridines into their (E)-isomers via addition of thiophenol to the
cyanomethylene moiety followed by oxidative syn-elimination reactions.
J. Org. Chem. 61, 6261–6267 (1996).
28. Griffith, W. P., Ley, S. V., Whitcombe, G. P. & White, A. D. Preparation and
use of tetra-n-butylammonium per-ruthenate (TBAP reagent) and tetra-n-
propylammonium per-ruthenate (TPAP reagent) as new catalytic oxidants
for alcohols. J. Chem. Soc. Chem. Commun. 1625–1627 (1987).
29. Bhattacharjee, A. & De Brabander, J. K. Synthesis of side chain truncated
apicularen A. Tetrahedron Lett. 41, 8069–8073 (2000).
30. Smith, A. B. III, Dong, S., Brenneman, J. B. & Fox, R. J. Total synthesis of
(þ)-sorangicin A. J. Am. Chem. Soc. 131, 12109–12111 (2009).
Methods
The reactions involving conjugated polyenes were carried out in the absence of light.
For experimental procedures and spectroscopic data of all new compounds, see
Supplementary Information.
Received 26 January 2012; accepted 12 March 2012;
published online 1 July 2012
Acknowledgements
References
The authors acknowledge the National Institutes of Health (GM54623) and the National
Science Foundation (CHE-0316689) for generous financial support, and the Royal Society
for a Wolfson Research Merit Award (to P.A.E.). The authors are also grateful to the EPSRC
National Mass Spectrometry Service Centre (Swansea, UK) for high-resolution
mass spectrometry. This Article is dedicated to Professor Robert H. Grubbs on the occasion
of his 70th birthday.
1. Arias, C. A. & Murray, B. E. Antibiotic-resistant bugs in the 21st century—
a clinical super-challenge. N. Engl. J. Med. 360, 439–443 (2009).
2. von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S. & Ha¨bich D.
Antibacterial natural products in medicinal chemistry—exodus or revival?
Angew. Chem. Int. Ed. 45, 5072–5129 (2006).
3. Fleming, A. On the antibacterial action of cultures of a Penicillium, with special
reference to their use in the isolation of B. influenzae. Br. J. Exp. Pathol. 10,
226–236 (1929).
Author contributions
P.A.E. managed the project, analysed data and prepared the manuscript with M-H.H.
and S.M. M.J.L. and M-H.H. devised the synthesis of the monomer and performed the
laboratory experiments. M-H.H. identified the significance of the salicylate molecular
switch and performed the laboratory work to complete the total synthesis of the natural
product. S.M. conducted key control experiments on the salicylates and identified the major
side product from the macrolactonization.
4. Eichner, S., Floss, H. G., Sasse F. & Kirschning A. New, highly active
nonbenzoquinone geldanamycin derivatives by using mutasynthesis.
ChemBioChem 10, 1801–1805 (2009).
5. Goss, R. J. M. et al. An expeditious route to fluorinated rapamycin analogues
by utilising mutasynthesis. ChemBioChem 11, 698–702 (2010).
6. Staunton, J. & Weissman, K. J. Polyketide biosynthesis: a millennium review.
Nat. Prod. Rep. 18, 380–416 (2001).
7. Hertweck, C. The biosynthetic logic of polyketide diversity. Angew. Chem. Int.
Ed. 48, 4688–4716 (2009).
8. Tsai, S.-C. et al. Crystal structure of the macrocycle-forming thioesterase domain
of the erythromycin polyketide synthase: versatility from a unique substrate
channel. Proc. Natl Acad. Sci. USA 98, 14808–14813 (2001).
Additional information
reprints. Correspondence and requests for materials should be addressed to P.A.E.
5
© 2012 Macmillan Publishers Limited. All rights reserved.